Real-time enrollment status for this primary immunodeficiencies clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:15 AM UTC
| NCT Number | NCT02579967 |
| Recruiting Status | Recruiting |
| Condition | Primary Immunodeficiencies |
| Phase | PHASE2 |
| Target Enrollment | 354 participants |
| Active Locations | 2 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | June 30, 2026 (2 weeks ago) |
As of July 18, 2026: Clinical trial NCT02579967 is currently recruiting participants. This phase2 study for primary immunodeficiencies is actively seeking new participants at 2 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02579967 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02579967 was last updated 2 weeks ago (June 30, 2026). HelloStudys verifies this status automatically.